Earnings Preview: ANI Pharmaceuticals (ANIP) Q2 Earnings Expected to DeclineZacks Investment Research • 07/29/20
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical StocksThe Motley Fool • 06/03/20
ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/09/20
ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 05/07/20
ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/27/20
ANI Pharmaceuticals (ANIP) Q4 Earnings and Revenues Lag EstimatesZacks Investment Research • 02/27/20
ANI Pharmaceuticals (ANIP) Lags Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/06/19
ANI Pharmaceuticals (ANIP) to Report Q3 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 10/29/19
ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19
Why Investors Have Severely Underestimated ANI Pharmaceuticals' And Its Cortrophin SNDASeeking Alpha • 07/25/19
ANI Pharmaceuticals Inc. (ANIP) CEO Arthur Przybyl on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19
ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 05/01/19
ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 04/18/19
ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 04/12/19